EYEG - .3901 Pre-market now at .41/.49 EyeGate Completes Enrollment and Receives Milestone Payment for Confirmatory Phase 3 Clinical Study of EGP-437 in Anterior Uveitis http://stockcharts.com/c-sc/sc?s=EYEG&p=D&b=5&g=0&i=t80248288159&r=1523019181857